OVERVIEW

The 13th University of Pennsylvania Inflammatory Bowel Disease Symposium will highlight the advances in the treatment of IBD. Lectures by nationally and internationally recognized experts will be followed by interactive case presentations and panel discussions. A wide array of topics will be discussed including pharmacologic therapies and surgical interventions and optimal use of imaging and endoscopy. Participants will receive a comprehensive overview of the latest available research and clinical information on evaluation and management of patients with IBD.

TARGET AUDIENCE

Specialties - FAMILY MEDICINE, INTERNAL MEDICINE, INTERNAL MEDICINE - Gastroenterology, SURGERY

This activity has been designed for gastroenterologists, gastrointestinal surgeons, gastroenterology fellows, internists, residents, physician assistants, nurse practitioners, clinical nurse specialists, dietitians, nutritionists and other health care professionals.

LEARNING OBJECTIVES

1. Appropriately prescribe biologics and other targeted therapies for IBD
2. Utilize biomarkers and therapeutic drug monitoring to improve outcomes
3. Implement treat to target strategies in the management of IBD
4. Successfully manage complications of IBD such as perianal fistula, stricture, and abscess

ACCREDITATION

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Penn Medicine designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.